Skip to content

Opening book details…

About this Medicine article

P4388Treatment decisions based on individual estimated lifetime benefit versus individual estimated 10-year absolute risk reduction: a cost-effectiveness analyses with PCSK9 inhibition by Berkelmans, G F N; Greving, J P; Van Der Graaf, Y; Visseren, F L J; Dorresteijn, J A N is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Berkelmans, G F N; Greving, J P; Van Der Graaf, Y; Visseren, F L J; Dorresteijn, J A N
Publisher
Oxford University Press; Oxford University Press (OUP); Elsevier BV (ISSN 0195-668X)
Published
2018
Field
Medicine (Health Sciences)

More by Berkelmans, G F N; Greving, J P; Van Der Graaf, Y; Visseren, F L J; Dorresteijn, J A N

Browse all works by Berkelmans, G F N; Greving, J P; Van Der Graaf, Y; Visseren, F L J; Dorresteijn, J A N